Skip to content
$
0.00
0
Cart
Search
(780) 448-0585
IOT.V 0.19 +0.01 +5.56%
|
OTCQB:IOTCF
Services
By Application
Anti-Adherence
Anti-Encrustation Testing
Antimicrobials
Environmental Bioburden Monitoring
Facility Water Testing
GMP Analytical Chemistry Testing Services
Medical Device Testing
MIC, MBC, MFC, Toxicology Testing
Microbiology Testing Services
Pharmaceutical & Drug Development
Stability Testing Services
Sterility Testing
By Method
Antimicrobial Effectiveness Testing USP <51>
BEST Assay™ Method
Environmental Bioburden Monitoring
GMP Analytical Chemistry Testing Services
MBEC Assay® Testing
Method Development and Validation Services
MIC, MBC, MFC, Toxicology Testing
By Industry
Compounding Pharmacies
Medical Device Testing
Pharmaceutical & Drug Development
Products
MBEC
InnovoSIL™ Silver
Resources
Investor Relations
Company
Our Team / History
Careers
Quality
Contact
Contact Us
Annual and Interim Financial Statements
April 1, 2026
Consolidated Financial Statements and MD&A for December 31, 2025 and 2024
September 30, 2025
Interim Financial Statements & MD&A for period ended 30 September 2025
June 30, 2025
Interim Financial Statements & MD&A for period ended 30 June 2025
March 31, 2025
Interim Financial Statements & MD&A for period ended 31 March 2025
December 31, 2024
Annual Financial Statements & MD&A For the 2024 year ended December 31
September 30, 2024
Interim Financial Statements & MD&A for period ended 30 September 2024
June 30, 2024
Interim Financial Statements & MD&A for period ended 30 June 2024
March 31, 2024
Interim Financial Statements & MD&A for period ended 31 March 2024
December 31, 2023
Annual Financial Statements & MD&A For the 2023 year ended December 31
September 30, 2023
Interim Financial Statements & MD&A for period ended 30 September 2023
June 30, 2023
Interim Financial Statements & MD&A for period ended 30 June 2023
March 31, 2023
Interim Financial Statements & MD&A for period ended 31 March 2023
Page
1
Page
2
Page
3
